secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vyome Holdings, Inc (HIND)
CIK:        0001427570
Form:       8-K
Filed at:   2024-12-02T23:59:59+00:00
Accession:  0001104659-24-124568
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

ReShape Lifesciences receives Nasdaq delisting notice for stockholders' equity below $2.5M
--------------------------------------------------------------------------------

- As of Sept 30, 2024, stockholders' equity was $1,487,000, below Nasdaq's $2.5M minimum.
- Company has 45 days to submit a compliance plan; if accepted, Nasdaq may grant up to 180-day extension.
- Intends to monitor performance and consider available options to regain compliance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1427570/000110465924124568/0001104659-24-124568-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1427570/000110465924124568/tm2419158d7_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-124568

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer